NO991693L - Forbindelser og metoder for diagnose av tuberkulose - Google Patents

Forbindelser og metoder for diagnose av tuberkulose

Info

Publication number
NO991693L
NO991693L NO991693A NO991693A NO991693L NO 991693 L NO991693 L NO 991693L NO 991693 A NO991693 A NO 991693A NO 991693 A NO991693 A NO 991693A NO 991693 L NO991693 L NO 991693L
Authority
NO
Norway
Prior art keywords
tuberculosis
compounds
polypeptides
methods
diagnosis
Prior art date
Application number
NO991693A
Other languages
English (en)
Other versions
NO991693D0 (no
Inventor
Steven G Reed
Yasir A W Skeiky
Davin C Dillon
Antonio Campos-Neto
Raymond Houghton
Thomas S Vedvick
Daniel R Twardzik
Michael J Lodes
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/818,111 external-priority patent/US6338852B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO991693D0 publication Critical patent/NO991693D0/no
Publication of NO991693L publication Critical patent/NO991693L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Forbindelser og metoder for diagnostisering av tuberkulose er beskrevet. Forbindelsene tilveiebragt inkluderer polypeptider som inneholder minst en antigendel eller en eller flere M. tuberkuloseproteiner, og DNA-sekvenser som koder for slike polypeptider. Diagnostiske kit som inneholder slike polypeptider eller DNA-sekvenser og en passende deteksjonsreagens kan bli brukt for deteksjon av M. tuberkuloseinfeksjon i pasienter og biologiske prerver. Antistoffer rettet mot slike polypeptider er også tilveiebragt.
NO991693A 1996-10-11 1999-04-09 Forbindelser og metoder for diagnose av tuberkulose NO991693L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72962296A 1996-10-11 1996-10-11
US08/818,111 US6338852B1 (en) 1995-09-01 1997-03-13 Compounds and methods for diagnosis of tuberculosis
PCT/US1997/018214 WO1998016645A2 (en) 1996-10-11 1997-10-07 Compounds and methods for diagnosis of tuberculosis

Publications (2)

Publication Number Publication Date
NO991693D0 NO991693D0 (no) 1999-04-09
NO991693L true NO991693L (no) 1999-06-09

Family

ID=27111919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991693A NO991693L (no) 1996-10-11 1999-04-09 Forbindelser og metoder for diagnose av tuberkulose

Country Status (11)

Country Link
EP (1) EP0934415A2 (no)
JP (1) JP2001500383A (no)
AU (1) AU4750597A (no)
BR (1) BR9712298A (no)
CA (1) CA2268036A1 (no)
CZ (1) CZ126699A3 (no)
IL (2) IL129389A0 (no)
NO (1) NO991693L (no)
PL (1) PL333304A1 (no)
TR (1) TR199901569T2 (no)
WO (1) WO1998016645A2 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
EP1003870A1 (en) * 1997-07-16 2000-05-31 Institut Pasteur A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
EP1484405A1 (en) * 1997-11-10 2004-12-08 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US7083796B2 (en) 2000-06-20 2006-08-01 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
EP2087906A1 (en) 1999-05-04 2009-08-12 The University of Medicine and Dentistry of New Jersey Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
AU779846B2 (en) * 1999-10-07 2005-02-17 Corixa Corporation Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
AU2001241738A1 (en) 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
WO2002004018A2 (en) * 2000-07-10 2002-01-17 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
WO2003000721A2 (en) 2001-06-22 2003-01-03 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
JP2005508613A (ja) 2001-07-04 2005-04-07 ヘルス プロテクション エージェンシー 潜伏中に発現されるマイコバクテリア抗原
US7105319B2 (en) * 2001-07-25 2006-09-12 Tosoh Corporation Oligonucleotides for detecting tubercle bacillus and method therefor
GB0125535D0 (en) * 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
CN102220357B (zh) 2004-11-16 2013-12-25 克鲁塞尔荷兰公司 包含重组病毒载体的多价疫苗
DK2457926T3 (da) 2005-04-29 2015-01-05 Glaxosmithkline Biolog Sa Ny fremgangsmåde til forebyggelse eller behandling af M. tuberkulose-infektion
CA2616766A1 (en) * 2005-07-26 2007-02-01 University Of Medicine And Dentistry Of New Jersey Antibody profiles characteristic of tuberculosis state
CN100999550B (zh) * 2006-01-10 2010-10-06 中国人民解放军第三○九医院 结核分枝杆菌融合蛋白及其应用
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
US9297803B2 (en) 2006-11-01 2016-03-29 Immport Therapeutics, Inc. Compositions and methods for immunodominant antigens
BR112012018669A2 (pt) 2010-01-27 2017-09-05 Glaxosmithkline Biologicals Sa Proteína rv3616c modificada, uso de uma proteína rv3616c modificada, polinucleotídeo, uso de um polinucleotídeo, composição farmacêutica, composição imunogênica, proteína de fusão, e, polipeptídeo.
CN115746092B (zh) * 2022-08-12 2024-08-13 齐鲁工业大学 具有抗氧化、抗衰老活性的钝顶螺旋藻藻蓝蛋白活性肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
EP0419355B1 (en) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
AU727602B2 (en) * 1995-09-01 2000-12-14 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
CA2230927A1 (en) * 1995-09-01 1997-03-13 Corixa Corporation Compounds and methods for diagnosis of tuberculosis

Also Published As

Publication number Publication date
NO991693D0 (no) 1999-04-09
IL129389A0 (en) 2000-02-17
WO1998016645A3 (en) 1998-08-06
JP2001500383A (ja) 2001-01-16
WO1998016645A2 (en) 1998-04-23
PL333304A1 (en) 1999-11-22
EP0934415A2 (en) 1999-08-11
CZ126699A3 (cs) 1999-09-15
AU4750597A (en) 1998-05-11
BR9712298A (pt) 2000-10-24
TR199901569T2 (xx) 2000-12-21
IL121936A0 (en) 1998-03-10
CA2268036A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
NO995690L (no) Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse
NO991693L (no) Forbindelser og metoder for diagnose av tuberkulose
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
NO20012812D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av chlamydiainfeksjon
DK1307564T3 (da) Forbindelser og fremgangsmåde til behandling og diagnose af chlamydiainfektion
WO2001062893A3 (en) Compounds and methods for diagnosis and immunotherapy of tuberculosis
NZ518917A (en) Compounds and methods for treatment and diagnosis of chlamydial infection
EP2192128A3 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
SE8701905L (sv) Foerfarande och kit foer diagnos av iga-nefropati
AU7312801A (en) Compositions and methods for the diagnosis and treatment of herpes simplex virusinfection
SE8900721D0 (sv) Methods for detection of antibodies to
EP1712629A3 (en) Compounds and methods for diagnosis of tuberculosis
RU96113950A (ru) Способ диагностики тубергкулеза почек
TH84254A (th) สารประกอบและวิธีสำหรับการวินิจฉัยวัณโรค
AR013326A1 (es) POLIPEPTIDO AISLADO, MOLECULA DE ADN, VECTOR DE EXPRESION RECOMBINANTE, CELULA HUESPED, METODO PARa DETECTAR LA INFECCION DE M.TUBERCULOSIS EN UNAMUESTRA BIOLOGICA, EQUIPO PARA DIAGNOSTICO, ANTICUERPO MONOCLONAL, Y ANTICUERPO POLICLONAL, PROTEINAS DE FUSION

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application